ALGA BIOLOGICS
Live / Registered — Registered (as of 24 Mar 2026)
What this means for you
Registered since 24 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79412399
- Registration number
- 8182125
- Mark type
- Design + words
- Filed
- 10 Oct 2024
- Published for opposition
- 03 Feb 2026
- Registered
- 24 Mar 2026
- Attorney of record
- James J. Bitetto
Goods and services
- Class 001 — Chemicals: Glycoproteins for industrial use; protein in raw material form for scientific and medical research; recombinant nucleic acid, other than for medical or veterinary purposes; enzymes for industrial use; enzymes for scientific use; enzymes for use in the industrial biotechnology and biopharmaceutical industry; enzymes other than for medical use for marking protein fractions; enzymes derived from biotechnological processes for industrial use; enzymes for protein hydrolysis, other than for medical or veterinary purposes; cell culture media for the biotechnology industry, other than for medical or veterinary purposes; nucleoproteins, other than for medical or veterinary purposes; biochemical products, namely, precursors for in-vitro genetic engineering; biochemical products, namely, monoclonal antibodies for in vitro scientific research use; biochemical preparations for in-vitro and in-vivo scientific use; biochemical preparations, other than for medical or veterinary purposes; plant extracts, other than essential oils, for the manufacture of cosmetics; proteins intended for the manufacture of food; protein in raw material form for manufacturing food for humans; raw proteins for scientific and medical research; raw proteins for use in industry; proteins for use in industry; proteins for the manufacture of cosmetic products; proteins for the food industry; proteins for the manufacture of food supplements; proteins for recombinant DNA techniques, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary use
- Class 005 — Pharmaceuticals: Human immunoglobulin for medical use; biotechnological preparations for medical use, namely, antibodies, recombinant proteins, and complex peptides for diagnostics and treatment of cancer and other human diseases; sanitary products, namely, formulation preparations for medical use for medicine; pharmaceutical products for the prevention, diagnostics, and treatment of cancer and other human diseases; veterinary products, namely, recombinant proteins, vaccines, and biologic therapeutics for veterinary use; food supplements; disinfectants; fungicides
- Class 042 — Scientific and technological services: Scientific research; technological research in the field of industrial biotechnology and biopharmaceuticals; engineering services, namely, technical testing in the field of industrial biotechnology and biopharmaceuticals; software development; software design; research and development of new products for third parties in the field of industrial biotechnology and biopharmaceuticals; scientific and technological research services, namely, conducting of technical project studies in the field of industrial biotechnology and biopharmaceuticals; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; software as a service (SaaS) services featuring software for managing, optimizing and monitoring recombinant protein production workflows in microalgae, including digital tracking of strains, culture conditions, expression data and analyses in the field of biotechnology; providing technology information in the field of industrial biotechnology and biopharmaceuticals; design and development of operating software for accessing and using a cloud computing network
Owner
- Alga Biologics, FR
- Alga Biologics, FR
- Alga Biologics, FR
Prosecution history
- 24 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 03 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Feb 2026 — PUBLISHED FOR OPPOSITION
- 28 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Oct 2025 — REFUSAL PROCESSED BY IB
- 16 Sept 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 16 Sept 2025 — REFUSAL PROCESSED BY MPU
- 06 Aug 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 05 Aug 2025 — NON-FINAL ACTION WRITTEN
- 01 Aug 2025 — ASSIGNED TO EXAMINER